While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >

Menu
0

While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >

0

Your Cart is Empty

Presentations

Main menu

 

  • NEW! Improved Adaptive Immune Receptor Repertoire Profiling for Biomarker Discovery (View Now | 23 min)
  • NEW! TCR and BCR Repertoire Analysis and Other Approaches for the Discovery of Drug Targets, Resistance Mechanisms and Biomarkers (View Now | 12 min)
  • NEW! An integrated multi-omics approach to identify molecular regulatory mechanisms in breast cancer development and progression (View Now | 30 min)
  • NEW! Adaptive Immune Receptor Profiling for Biomarker Discovery (View Now |  19 min)
  • A functional map of LncRNAs involved in adaptation pathways of breast cancer cells (View Now | 20 min)
  • Perturb-seq analysis of TNFalpha-induced transcriptional response (View Now| 17 min)
  • Flexible & Scalable Genetic Screens for Novel Therapeutic Drug Discovery: An Overview of Noteworthy Case Studies (View Now | 48 min)
  • Immunophenotyping of TCR and BCR Clonotypes (View Now| 26 min)
  • Spatial Transcriptomics: Uses (and Limitations) of a Powerful Technique (View Now | 41 min)
  • Network-anchored functional genomics identifies intra-tumoral axes of vulnerability in pancreatic cancer (View Now | 50 mins) 
  • Lineage Tracing to Dissect Functional Heterogeneity of Tumor Cells (View Now | 50 mins) 
  • CRISPR/Cas9 screens to investigate mechanisms of Cancer Drug Resistance (View Now | 50 mins)
  • Critical role of ARID1A in determining the luminal identity and therapeutic response in estrogen receptor positive (ER+) breast cancer (View Now | 25 mins)
  • NGS technologies and RNA Expression profiling for Single-Cell Genetic Analysis (View Now | 27 mins)
  • Application of DriverMap™Target RNA-Sequencing in Drug Screening (View Now | 20 mins)
  • Efficient Tools to Enable Drug Target and Biomarker Discovery: An Introduction to Cellecta Technologies (View Now | 20 mins)
  • Customer Presentation: D2G Oncology – Quantitative and Multiplexed in vivo Functional Cancer Genomics Using Barcoded CRISPR Libraries (View Now | 20 mins)
  • Assessment of Immune status and Biomarker Discovery using Blood Transcriptomics (View Now | 16 mins)
  • Loss-of-Function Genetic Screens with RNAi and CRISPR Libraries (View Now | 55 mins)
  • Molecular Snapshot with DriverMap™ Targeted Expression Profiling Assay (View Now | 25 mins) 

Oral Presentations

  • DriverMap™: Profiling the Tumor Microenvironment and Biomarkers with CancerNet™, April 2016, AACR Annual Meeting (PDF)
  • CRISPR and RNAi Loss-of-Function Genetic Screens, March 2016, MMTC (PowerPoint Slide Show)

For a list of the upcoming events we’re attending, please visit Cellecta’s Events page.